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Abstract
Background: Internet-based surveillance systems to monitor influenza-like illness (ILI) have advantages over
traditional (physician-based) reporting systems, as they can potentially monitor a wider range of cases (i.e.
including those that do not seek care). However, the requirement for participants to have internet access and to
actively participate calls into question the representativeness of the data. Such systems have been in place in a
number of European countries over the last few years, and in July 2009 this was extended to the UK. Here we
present results of this survey with the aim of assessing the reliability of the data, and to evaluate methods to
correct for possible biases.
Methods: Internet-based monitoring of ILI was launched near the peak of the first wave of the UK H1N1v
influenza pandemic. We compared the recorded ILI incidence with physician-recorded incidence and an estimate
of the true number of cases over the course of the epidemic. We also compared overall attack rates. The effect of
using different ILI definitions and alternative denominator assumptions on incidence estimates was explored.
Results: The crude incidence measured by the internet-based system appears to be influenced by individuals who
participated only once in the survey and who appeared more likely to be ill. This distorted the overall incidence
trend. Concentrating on individuals who reported more than once results in a time series of ILI incidence that
matches the trend of case estimates reasonably closely, with a correlation of 0.713 (P-value: 0.0001, 95% CI: 0.435,
0.867). Indeed, the internet-based system appears to give a better estimate of the relative height of the two waves
of the UK pandemic than the physician-recorded incidence. The overall attack rate is, however, higher than other
estimates, at about 16% when compared with a model-based estimate of 6%.
Conclusion: Internet-based monitoring of ILI can capture the trends in case numbers if appropriate weighting is
used to correct for differential response. The overall level of incidence is, however, difficult to measure. Internet-
based systems may be a useful adjunct to existing ILI surveillance systems as they capture cases that do not
necessarily contact health care. However, further research is required before they can be used to accurately assess
the absolute level of incidence in the community.
Background
Every year influenza A viruses cause epidemics leading
to high morbidity and mortality - approximately 3 to 5
million cases and between 250,000 and 500,000 deaths
worldwide [1]. The majority of complications usually
occur in the young, elderly and the immunologically
compromised. Although immunity from the virus may
be long term, this immunity is subtype and strain speci-
fic which means that as long as the virus retains its abil-
ity to mutate rapidly recurring outbreaks will continue
to be seen [1-3].
On the 12th of June 2009, the WHO alerted the world
of an influenza pandemic caused by a novel H1N1 influ-
enza strain. The UK epidemic was characterised by two
peaks: one in late July, and another in late October [4].
Traditional influenza monitoring methods have relied
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on sentinel networks of physicians to diagnose and
report ILI (influenza-like-illness) [5]. These systems have
been the mainstay of influenza surveillance for many
years. However, they have a number of potential draw-
backs, particularly during a pandemic, as they require
individuals to attend physicians when they are ill. An
unknown proportion of cases do not attend heath care,
and this proportion may vary with age, sex or other
social groups, and may change over the course of an
epidemic, particularly if there are changes in levels of
public concern, capacity problems, or mechanisms to
divert patients away from physician’s offices (such as
was implemented in the UK during 2009). In response,
internet-based surveillance has been suggested as a
means of rapidly assessing the level of illness in the
community. Two approaches have been implemented.
First, people’s internet browsing behaviours have been
used as proxies for ILI incidence [6-13]. As these only
record proxy measures of influenza, they are limited in
their usefulness (they cannot, for instance, track health-
care usage, or the clinical spectrum of cases). An alter-
native is to recruit members of the public to record,
using an internet-based questionnaire, specific symp-
toms over time. That is, to recruit an internet-based
cohort and survey patterns of illness and health care
attendance in these individuals. Such systems have been
implemented in Belgium and the Netherlands (under
the name “Der Grote Griepmeting” - the Great Influ-
enza Survey, GIS) in 2003 [14], Portugal ("Gripenet”) in
2005 [15], and in Italy ("Influweb”) in 2007 [16]. Results,
in non-pandemic years, appear to be highly correlated
temporally with those obtained through traditional sur-
veillance methods [17-19], and the systems may be able
to detect increased influenza activity more rapidly than
GP-based surveillance [17-19]. The incidence recorded
in these systems appears to be consistent between coun-
tries, and is consistently higher than that reported by
GP-based systems [19]. However, it is not clear exactly
what is being measured by the internet-based surveil-
lance systems, as the sample is unlikely to be represen-
tative and it is not clear how to calculate the
appropriate denominator (see below). We adapted these
internet-based influenza monitoring systems to the UK
in July 2009 (during the first wave of the UK pandemic
of H1N1v [20]). Here we present data collected using
this system. We examine different methods of calculat-
ing incidence from such a system, including examining
different ways of defining influenza-like-illness. We
compare our incidence estimates to the case estimates
generated by the Health Protection Agency (HPA) [21],
noting that these case estimates should themselves be
treated with some caution, and with the ILI attack rates
for England and Wales. The aim is to assess how well
internet-based surveillance of Influenza performs when
compared to a range of other measures.
Methods
Implementing the UK flusurvey
The UK flusurvey was launched in mid-July 2009. With
the help of a publicity campaign involving television,
radio, and newspaper coverage and word of mouth, over
5,000 participants were recruited in the first week. Parti-
cipants were recruited from all parts of the UK (Addi-
tional file 1).
The study was approved by the London School of
Hygiene and Tropical Medicine Ethics Committee
(Application number 5530).
Registration for the UK flusurvey took place through
the web page http://www.flusurvey.org.uk. Upon regis-
tration, following provision with a password-protected
account, participants were requested to complete a
background questionnaire. This covered age, gender,
household size and composition, occupation, location
of home and workplace, receipt of influenza vaccine
during the 2008/2009 influenza season, and member-
ship of a risk group (self-report of any of the follow-
ing: diabetes, asthma, other chronic lung disease,
immunocompromised, chronic heart disease, other
chronic disease, pregnant - individuals reporting any
of these are referred to hereafter as being in a “risk
group”). As well as registering on their own behalf,
participants were able to create accounts on behalf of
other members of their family/household, thus
enabling, for instance, parents to record data about
their children.
Each week, whether or not they had symptoms, parti-
cipants were asked to complete a symptoms question-
naire (see below) and a questionnaire about their social
contacts. A questionnaire about vaccine uptake was
added in autumn 2009, once the pandemic-specific vac-
cine became available. Each questionnaire was intended
to take no more than a couple of minutes to complete.
An email newsletter was sent to participants each
week to remind them to complete the symptoms ques-
tionnaire. To maintain participants’ interest in the sur-
vey the weekly newsletters contained a summary of the
latest influenza facts and news, and the flusurvey web-
site was updated on a daily basis with items including
the estimated incidence and the spatial distribution of
cases being continuously updated.
Symptoms questionnaire
The symptoms questionnaire asked participants to
record which, if any, symptoms they had experienced
recently. Participants were asked to select symptoms
from a list, shown in Table 1.
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Participants who reported the presence of symptoms
were asked when their symptoms began and whether
fever onset (if any) was rapid; they were asked about
healthcare seeking behaviour - whether they consulted a
medical professional and, if so, whether in person or by
phone/internet, who they consulted, and when the con-
sultation took place; they were asked whether they took
any medication as a result of their symptoms, and, if so,
when; they were asked whether they took time off work
as a result of their symptoms and, if so, for how long
they were off work. Participants were also asked whether
they had encountered anyone with flu like symptoms in
the past week.
Sample used in the analysis
Here we analyse data collected via the symptoms
questionnaire from the period 16/07/09 until 31/12/09.
In all, 5,738 participants contributed 20,901 records to
this dataset.
In an attempt to reduce the effect of individuals who
only register and take part as a one-off response to their
current symptoms we followed the method of Friesema
et al. [17], by restricting our dataset to participants’ sec-
ond and subsequent reports (15,163 records). We com-
pared estimates of incidence from this dataset with those
produced using a third dataset that contained all reports
made by participants who participated more than once
(17,532 reports), and found that they were very similar.
Here, therefore, we use the latter dataset, and will from
now refer to this sample as the “censored sample”.
Demographic description of Flusurvey participants
The censored sample contains 2,369 participants who
contributed 17,532 completed symptoms questionnaires.
A comparison of this sample with the UK
population [22] makes it clear that our sample is not
demographically or geographically representative (Figure
1 and Table 2). 2% (49 out of 2369) did not report their
age or sex. 67% of Flusurvey participants were women.
People aged under 15 and over 60 are under-sampled;
88% were from England, London in particular being
over-sampled.
Flusurvey participants were similar, in terms of risk
status, to the general population [23], with the exception
of children (Figure 2). These differences could be partly
explained by differences in definitions - particularly for
asthma (respondents could well have reported mild and/
or intermittent asthma which would not necessarily put
them in a risk group, according to the definition usually
used in the UK [24]). The Flusurvey seasonal flu vaccine
uptake for last year in the under 65 risk group was
about 40% when compared with the UK (47.1%) and in
the 65+ age group it was about 68% compared to the
UK (74%) [25].
Weighting
Because of the demographic biases contained within our
sample, in order to allow comparison between influenza
statistics derived using the Flusurvey data with those
estimated for the UK [21,23], we consider reweighting
our sample in the analysis that follows. To do this we
weight our sample according to age and gender. We
split our sample into age categories < 1, 1 - 4, 5 - 14,
15 - 24, 25 - 44, 45 - 64 and 65+ to match the UK cen-
sus age distribution. Each individual is assigned a weight
according to the following formula [26]:
W P Pi i
UK
i
Flusurvey/=
Where,
Wi = Weight of individual i
Table 1 The list of symptoms used in the symptoms
questionnaire
1. Blocked/runny nose
2. Cough
3. Sore throat
4. Headache
5. Muscle pain and/or joint pain
6. Chest pain
7. Stomach ache
8. Diarrhoea
9. Nausea
10. Chills
11. Weakness
12. Eye irritation
13. Fever
14. No symptoms
Participants were asked to select any symptoms that applied to them.
Figure 1 Comparison of the flusurvey population in different
age and gender categories with the UK population [22].
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Pi
UK = Proportion of the UK population in the same
age and gender group as individual i
Pi
Flusurvey = Proportion of the Flusurvey population in
the same age and gender group as individual i
Analysis and calculations were carried out in Stata 11
and Excel 2007.
Defining influenza-like-illness
In an ideal world it would be possible to use a simple
list of symptoms to determine, with perfect sensitivity
and specificity, whether someone had experienced an
influenza infection. However, the symptoms of influenza
are subject to too much variation from person to per-
son, and there are too many other infections with simi-
lar symptoms. Therefore, instead, we seek to use the
symptoms questionnaire to decide which participants
had experienced ILI. This distinction between influenza
itself and influenza-like-illness is one made by most
public health bodies [27,28], in the absence of laboratory
confirmation.
ILI can be determined using a symptoms list but, to
further complicate matters, several different definitions
were in use during the H1N1v pandemic. For example,
the Health Protection Agency (HPA) defined ILI as
“Fever plus two or more of the following symptoms -
cough, sore throat, runny nose, limb/joint pain, headache,
vomiting/diarrhoea“ [27], whereas the US Centers for
Disease Control and Prevention (CDC) defined it as
“Fever plus cough plus headache plus any of the following
symptoms - runny nose, blocked nose, joint pain, muscle
pain, weakness, sore throat, chest pain, abdominal pain,
nasal congestion) [28]. The GIS, on which the UK flusur-
vey was based, uses the following definition of ILI [17]: “a
sudden onset of fever with muscle pain accompanied by
either a cough, sore throat or chest pain“.
We compare these three definitions to explore the
effect they would have on estimated incidence of ILI.
However, for comparability with previous work [19],
and to allow data to be quickly compared from country
to country, we will make use of the GIS definition of ILI
unless stated otherwise.
Because not every participant recorded the date of
symptom onset, and because of the difficulty in determin-
ing an appropriate denominator (see below), we measure
ILI incidence in week j as the number of participants
recording, in week j, symptoms consistent with ILI.
Defining a denominator for incidence estimation
Different numbers of participants completed the
symptoms questionnaire each week. Therefore, it would
be misleading simply to report the number of incidences
of ILI week by week. Instead, we consider an appropri-
ate denominator, to allow us to estimate ILI incidence
rates. The key to calculating this denominator is to
determine who in the sample population is at risk of
acquiring ILI. The most straightforward approach is to
take as the denominator for any given week all those
who completed the symptoms questionnaire that week.
However, although we continually encouraged those
without symptoms to report their lack of symptoms, it
is highly probable that individuals were more motivated
to complete the surveys on those weeks when they
experienced symptoms; thus, one could argue that the
denominator should include all flusurvey participants,
whether or not they completed the symptoms question-
naire that week.
Another issue arises when we consider in more detail
what is actually being measured; although we classify
symptoms as “ILI” or “non-ILI”, it is likely that during
summer/autumn 2009 much of what was classified as
ILI was in fact H1N1v influenza. If this is so, then parti-
cipants will be unable to experience a second case of
Table 2 Comparison of the spatial distribution of our
sample with the UK general population [22]
Region Flusurvey Population
(2369)
UK Population
(61383200)
East Midlands 5% 7%
East of England 12% 9%
London 23% 12%
North East 2% 4%
North West 8% 11%
South Central 9% 7%
SE Coast 7% 7%
South West 8% 8%
West Midlands 5% 9%
Yorkshire & the
Humber
8% 8%
Wales, Scotland &
NI
11% 16%
Unknown 2% -
Figure 2 Proportion of individuals in an influenza risk group,
comparing the population of England with English Flusurvey
participants [22,23].
Tilston et al. BMC Public Health 2010, 10:650
http://www.biomedcentral.com/1471-2458/10/650
Page 4 of 9
“ILI”, and should be removed from the population con-
sidered to be at risk. We examine two possibilities: the
first, in which we assume that participants could experi-
ence more than one case of ILI, and that they are imme-
diately at risk of subsequent infection (i.e. a susceptible-
infected-susceptible (SIS) infection); the second in which
we assume that ILI represents H1N1v, and that partici-
pants are removed from the population at risk once
they have experienced ILI (i.e. a susceptible-infected-
removed (SIR) infection).
In summary, we have 4 different methods of calculat-
ing a plausible denominator: either SIS or SIR, and
either assuming the weekly population or the total
population to be at risk. In what follows, we describe
these 4 possibilities as
• SIS week
• SIS sample
• SIR week
• SIR sample
Unless otherwise stated we use the SIS week assump-
tion for incidence.
Comparator estimates of incidence
The standard measure of ILI incidence in England and
Wales is the Royal College of General Practitioners
Weekly Returns Service (RCGP). This is a sentinel
GP-based scheme. A small fraction of the cases are
swabbed and tested virologically to determine their
infection status. During the H1N1 epidemic, the HPA
also estimated weekly case numbers. These estimates
took into account the fraction of cases attending GP
surgeries and the National Pandemic Flu Service (NPFS
- an internet and telephone based service that was set-
up in July 2009 to help ease the burden on GPs and the
NHS Direct) that were virologically confirmed. There
was a marked difference in confirmation rates between
the first and second wave of the 2009 epidemic, so that
although the summer wave appeared to be much higher
than the autumn wave according to the RCGP scheme,
the estimated true height of the second wave was about
equal to the first wave (Figure 3). The relative peak in
deaths over the two waves closely matches the peaks in
the HPA case estimates [29]. For these reasons we
assume that the HPA case estimates give a more accu-
rate picture of the true influenza incidence than the
RCGP consultation rate (though it should be noted that
the HPA case estimates are estimates of H1N1v influ-
enza, and ignore other causes of ILI).
Results
We analysed the Flusurvey data from week 29 2009 up
to week 53 2009. This dataset contained 5,738
participants out of whom 3,370 reported only once (Fig-
ure 4). Figure 5 (also see Additional file 2) demonstrates
that this crude dataset considerably overestimates the
relative height of the first peak when compared with the
HPA case estimates, while the censored (and weighted)
dataset of 2,369 people gives a better indication of the
second peak. Figure 6 indicates that this may be due to
many people being motivated to take part at the begin-
ning of the survey because they themselves had flu-like
symptoms. A Pearson’s correlation test with the
censored and weighted dataset against the HPA case
estimates for week 30 to week 53 gives a value of 0.713
(P-value: 0.0001, 95% CI: 0.435, 0.867) as compared to
the correlation coefficient of the censored (without
weighting) dataset of 0.699 (P-value: 0.0001, 95% CI:
0.412, 0.860). The relative height of the two peaks when
using the censored and weighted dataset is in reasonably
close agreement with the relative heights of the two
Figure 3 Comparison of weekly ILI incidence as calculated by
the RCGP with the weekly HPA case estimates.
Figure 4 Total number of reports per participant in the crude
(complete) dataset.
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HPA case estimate peaks. In contrast the RCGP system
reported a much higher first wave (Figure 3).
About 17% (391 out of 2,369) of our participants had
ILI at least once, out of whom 29% (113 out of 391)
said they were in the risk group, while 8% (33 out of
391) said they were health care workers. About 43%
(170 out of 391) of our ILI cases claimed to have met
an infectious contact in the week prior to their illness.
On exploring the effect of using different definitions
of ILI (Figure 7, also see Additional file 3), we see that
all definitions follow the same broad pattern, with peaks
in incidence in the summer and the autumn. As might
be expected from the definitions, the incidence
calculated using the HPA definition is higher than that
calculated using the more stringent GIS and CDC defi-
nitions. A comparison of the overall attack rates as esti-
mated from the Flusurvey data for England according to
these various definitions with English attack rates calcu-
lated by Baguelin et al. [23], for the same time period,
shows that the Flusurvey attack rates are significantly
higher (Figure 8). Our overall attack rate according to
the GIS definition [17] is 16% while the overall attack
rate for England (HPA estimates) is 6% [23]. 1.9% of our
sample reported visiting a GP for ILI over the time per-
iod (4% visited or telephoned the surgery) compared
Figure 5 Time series of the proportion of participants
reporting ILI each week (using the GIS definition of ILI). Three
different flusurvey incidence curves are plotted: one that uses the
crude (complete) dataset, one using the censored dataset (ignoring
all participants’ who participated only once) and one using the
censored dataset and reweighting the population to account for
demographic unrepresentativeness, compared with the cases
estimated by the HPA [21]. All curves are plotted using a 3-week
moving average; plots without this moving average can be found in
the Supplementary material.
Figure 6 Comparison of the weekly symptoms questionnaires
that were returned with the number of ILI reports for the
same week, in the crude (complete) dataset.
Figure 7 Comparison of ILI incidence according to different
definitions of ILI with the HPA’s estimated ILI cases
[17,21,27,28]. As in Fig 3, the denominator used is those
participants who completed the symptoms questionnaire on the
week in question. All curves are plotted using a 3-week moving
average; plots without this moving average can be found in the
Supplementary material.
Figure 8 The estimated attack rates using 3 different
definitions of ILI, broken down into age groups, along with
estimated attack rates by the HPA [23]. The attack rates for the
HPA estimated cases have been calculated based on Baguelin
et al. [23] method.
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with a cumulative GP consultation rate for ILI of 1% in
the RCGP system [21].
In Figure 9 (also see Additional file 4) we explore the
impact of different ways of calculating the denominator
in our incidence estimates. As we would anticipate,
using the entire sample as the denominator results in a
lower incidence estimate and a relatively higher second
wave than when only using those participants who
report in a given week. The fact that the SIS method
produces a larger estimate of incidence than the SIR
method suggests that some participants experienced
repeated infections of ILI. The reinfection rates accord-
ing to GIS (82/391) and HPA (111/520) definitions of
ILI is 21% and for CDC definition is 17% (54/313).
Discussion
Data from the UK suggests that the standard (GP-based)
surveillance of ILI during the 2009 pandemic gave a dis-
torted view of epidemic progress. In particular, the
height of the summer peak was exaggerated in compari-
son to the autumn peak (Figure 3). This occurred
because of changes in the pattern of access to care that
occurred during the epidemic. For instance, data from
the Flusurvey suggests that about 45% of those with ILI
sought medical attention in July, dropping to around
20% in August, and recovering again to around 30%
during the autumn peak (Brooks-Pollock E, Tilston N,
Edmunds WJ, Eames KTD: Re-estimating H1N1 cases
numbers in England in light of changing health-seek-
ing behaviour Submitted). To get a clearer picture of
the time course of the epidemic the HPA instigated ran-
dom testing of patients accessing different health-care
settings, which allowed the true numbers of cases to be
estimated. However, this is expensive and induced
further delays in the data stream. As is shown here,
internet-based monitoring of ILI in the community can
provide a direct and timely alternative - the relative size
and timing of the peaks being close to the adjusted
HPA case estimates. Because data were collected from
people who did not attend health care, it is likely that
internet-based surveillance captures a wider range of
cases than traditional (i.e. GP-based) surveillance sys-
tems, and allows changes in utilisation of care to be
monitored and accounted for in real-time. Internet-
based surveillance is relatively quick and inexpensive to
initiate, and is straightforward to scale up. However, as
is also evident from this study considerable care must
be taken to appropriately account for the different biases
in the system.
The level of incidence observed is dependent on the
definition of ILI and the denominator used. While there
is a marked difference in the attack rates generated by
different ILI definitions, all are higher than that esti-
mated by a mathematical model [23]. There are a num-
ber of possible explanations for this observation: first,
not everything that is diagnosed as ILI will have been
H1N1v influenza - the fact that some individuals
reported more than one episode of ILI illustrates this.
Second, the survey may result in response biases; we
have, through weighting the sample, attempted to adjust
for demographic (age and gender) biases in response,
but it is not possible to adjust for unknown confoun-
ders. In addition it is likely that individuals preferentially
took part when they were infected. Although censoring
the sample by removing those individuals from the ana-
lysis who only report on one occasion reduces the bias
somewhat, as illustrated by the estimated incidence
curves, it is likely that some remains. In presenting the
use of different denominators for incidence estimates we
have explored two possibilities: one that assumes that
completion of the survey in a given week is independent
of symptom status, and the other that assumes that all
participants with ILI in a given week will complete the
survey that week. It is likely that reality lies somewhere
in between, and further work is clearly needed to deter-
mine the nature of this response bias and how to adjust
for it.
In making comparisons between Flusurvey estimates
and HPA case numbers, it must be noted that the HPA
figures are themselves only estimates, based on recorded
treatment seeking behaviour (contact with GPs and use
of the National Pandemic Flu Service), adjusted for
antiviral positivity and a constant which represents the
fraction of cases that consult GPs. Given that treatment-
seeking behaviour changed over the course of the pan-
demic, there is no authoritative time series against
which to compare Flusurvey incidence estimates.
Furthermore, because our internet-based survey mea-
sures ILI, we would expect the difference between the
Flusurvey and HPA case estimates to be largest when
Figure 9 Incidence according to different denominators
compared with the case estimates of the HPA [21]. All curves
are plotted using a 3-week moving average; plots without this
moving average can be found in the Supplementary material.
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pandemic H1N1v was rare. This, indeed, was the case,
with the Flusurvey (and RCGP) recording continuing ILI
activity through December, whereas the HPA case esti-
mates (which account for the fraction that were con-
firmed as H1N1v) were very low at this point (Figure 5).
It is likely that systems such as the UK Flusurvey will
be increasingly used in the future, for both pandemic
and seasonal influenza, as they are a relatively low-cost
method of collecting ILI data, and allow access to cases
that do not necessarily seek formal care. However, these
systems are novel and need to be properly evaluated.
One suggestion for validation would be to virologically
test patients with ILI symptoms (perhaps by sending out
self-swabbing packs to participants who report ILI
symptoms), similar to the testing scheme implemented
for the NPFS during the 2009 epidemic.
Conclusions
Internet-based surveillance has the potential to capture
a wider range of cases than traditional (GP-based) sur-
veillance systems, as well as to track changes in health-
care attendance patterns in real-time. Our results
suggest that trends in incidence can be captured by
such systems perhaps even more reliably than standard
GP-based systems, but it remains unclear how accurate
they are for estimating the absolute level of incidence.
Internet-based surveillance does not offer a replacement
of traditional GP-based methods, but can provide an
important adjunct, allowing the collection of valuable
additional information.
Additional material
Additional file 1: Map from the flusurvey showing the geographical
spread of participants. This shows the approximate location of
flusurvey users: red points indicate people with influenza-like symptoms,
blue indicates people with other respiratory symptoms and green
indicates people who do not have respiratory symptoms.
Additional file 2: Time series of the proportion of participants
reporting ILI each week (using the GIS definition of ILI), without
moving averages. Three different flusurvey incidence curves are plotted:
one that uses the crude (complete) dataset, one using the censored
dataset (ignoring all participants’ who participated only once) and one
using the censored dataset and reweighting the population to account
for demographic unrepresentativeness, compared with the cases
estimated by the HPA [21].
Additional file 3: Comparison of ILI incidence according to different
definitions of ILI with the HPA’s estimated ILI cases [17,21,27,28>28],
without moving averages. As in additional file 1, the denominator used
is those participants who completed the symptoms questionnaire on the
week in question.
Additional file 4: Incidence according to different denominators
compared with the case estimates of the HPA, without moving
averages.
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